Article
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
6 Jun 2021
Abstract excerpt
BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most common types in the world with a high mortality rate. Despite advances in treatment strategies, the overall survival (OS) remains short. Our study aims to establish a reliable prognostic signature closely related to the survival of LUAD patients that can better predict prognosis and possibly help with individual monitoring of LUAD patients. METHODS: Raw...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
